Dow Down 311 Points On Losses For Shares Of Nike, Amgen

Dow Jones
Sep 26

DJ Dow Down 311 Points On Losses For Shares Of Nike, Amgen

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is trading down Thursday afternoon with shares of Nike and Amgen seeing the biggest drops for the price-weighted average.

Shares of Nike (Nike Inc. Cl B) and Amgen (Amgen Inc.) have contributed to the index's intraday decline, as the Dow (Dow Jones Industrial Average) was most recently trading 311 points (0.7%) lower.

Nike's shares have dropped $1.98, or 2.8%, while those of Amgen are off $7.56, or 2.7%, combining for an approximately 59-point drag on the Dow.

Also contributing significantly to the decline are Salesforce (Salesforce Inc.), Merck (Merck & Co. Inc.), and Caterpillar (Caterpillar Inc.).

A $1 move in any one of the 30 components of the Dow equates to a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled September 25, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

September 25, 2025 14:02 ET (18:02 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10